サマリー

バイオ医薬品の世界市場 2024-2028
バイオ医薬品市場は2023〜2028年に2040億9000万米ドル成長し、予測期間中のCAGRは7.98%で加速すると予測される。この調査レポートは、バイオ医薬品市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、健康障害の有病率の増加、高齢者人口の増加、生物学的製剤の標的治療メカニズムによって牽引されています。
Technavioのバイオ医薬品市場は以下のように区分されます：
製品別
- モノクローナル抗体
- 組み換え成長因子
- ワクチン
- 組み換えホルモン
- その他
用途別
- 腫瘍学
- 自己免疫疾患
- 代謝障害
- ホルモン障害
- その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間のバイオ医薬品市場の成長を牽引する主な要因の1つとして、ワクチン生産の増加を挙げている。また、ライフサイエンス分野への投資の増加や、市場ベンダーによる買収の増加も、市場の大きな需要につながるだろう。
当レポートでは、バイオ医薬品市場について以下の分野をカバーしています：
- バイオ医薬品市場のサイジング
- バイオ医薬品市場の予測
- バイオ医薬品市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上させるのに役立つよう設計されており、これに沿って本レポートでは、AbbVie Inc、アスペンバイオ、アステラス製薬、アストラゼネカ、バイエル、バイオジェン、ブリストル・マイヤーズ・スクイブ、イーライリリー、F.ホフマン・ラ・ロシュ、イプセン・ファーマ、ジョンソン・エンド・ジョンソン、メルク、ノバルティス、ノボノルディスク、ファイザー、サノフィ、武田薬品工業、バーテックス・ファーマシューティカルズ、バーテックス・ファーマシューティカルズなどです。Ltd.、Vertex Pharmaceuticals Inc.である。また、バイオ医薬品市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/bio-pharma-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global bio-pharma market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global bio-pharma market 2018 - 2022 ($ billion)
o 4.2 Product Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
o 4.3 Application Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Monoclonal antibodies - Market size and forecast 2023-2028
o Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
o 6.4 Recombinant growth factors - Market size and forecast 2023-2028
o Exhibit 38: Chart on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Recombinant growth factors - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Recombinant growth factors - Year-over-year growth 2023-2028 (%)
o 6.5 Vaccines - Market size and forecast 2023-2028
o Exhibit 42: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
o 6.6 Recombinant hormones - Market size and forecast 2023-2028
o Exhibit 46: Chart on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Data Table on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
o Exhibit 48: Chart on Recombinant hormones - Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Recombinant hormones - Year-over-year growth 2023-2028 (%)
o 6.7 Others - Market size and forecast 2023-2028
o Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.8 Market opportunity by Product
o Exhibit 54: Market opportunity by Product ($ billion)
o Exhibit 55: Data Table on Market opportunity by Product ($ billion)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 56: Chart on Application - Market share 2023-2028 (%)
o Exhibit 57: Data Table on Application - Market share 2023-2028 (%)
o 7.2 Comparison by Application
o Exhibit 58: Chart on Comparison by Application
o Exhibit 59: Data Table on Comparison by Application
o 7.3 Oncology - Market size and forecast 2023-2028
o Exhibit 60: Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Oncology - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
o 7.4 Autoimmune disorder - Market size and forecast 2023-2028
o Exhibit 64: Chart on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on Autoimmune disorder - Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Autoimmune disorder - Year-over-year growth 2023-2028 (%)
o 7.5 Metabolic disorder - Market size and forecast 2023-2028
o Exhibit 68: Chart on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Data Table on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
o Exhibit 70: Chart on Metabolic disorder - Year-over-year growth 2023-2028 (%)
o Exhibit 71: Data Table on Metabolic disorder - Year-over-year growth 2023-2028 (%)
o 7.6 Hormonal disorder - Market size and forecast 2023-2028
o Exhibit 72: Chart on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Data Table on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
o Exhibit 74: Chart on Hormonal disorder - Year-over-year growth 2023-2028 (%)
o Exhibit 75: Data Table on Hormonal disorder - Year-over-year growth 2023-2028 (%)
o 7.7 Others - Market size and forecast 2023-2028
o Exhibit 76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 78: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 79: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 7.8 Market opportunity by Application
o Exhibit 80: Market opportunity by Application ($ billion)
o Exhibit 81: Data Table on Market opportunity by Application ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 83: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 84: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 85: Chart on Geographic comparison
o Exhibit 86: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 103: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 China - Market size and forecast 2023-2028
o Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.9 Germany - Market size and forecast 2023-2028
o Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.10 France - Market size and forecast 2023-2028
o Exhibit 115: Chart on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 116: Data Table on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 117: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 118: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 121: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 122: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 125: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 127: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 128: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 129: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 130: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 131: AbbVie Inc. - Overview
o Exhibit 132: AbbVie Inc. - Product / Service
o Exhibit 133: AbbVie Inc. - Key news
o Exhibit 134: AbbVie Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 135: Amgen Inc. - Overview
o Exhibit 136: Amgen Inc. - Product / Service
o Exhibit 137: Amgen Inc. - Key offerings
o 12.5 Astellas Pharma Inc.
o Exhibit 138: Astellas Pharma Inc. - Overview
o Exhibit 139: Astellas Pharma Inc. - Product / Service
o Exhibit 140: Astellas Pharma Inc. - Key news
o Exhibit 141: Astellas Pharma Inc. - Key offerings
o 12.6 AstraZeneca Plc
o Exhibit 142: AstraZeneca Plc - Overview
o Exhibit 143: AstraZeneca Plc - Product / Service
o Exhibit 144: AstraZeneca Plc - Key news
o Exhibit 145: AstraZeneca Plc - Key offerings
o 12.7 Bayer AG
o Exhibit 146: Bayer AG - Overview
o Exhibit 147: Bayer AG - Business segments
o Exhibit 148: Bayer AG - Key news
o Exhibit 149: Bayer AG - Key offerings
o Exhibit 150: Bayer AG - Segment focus
o 12.8 Biogen Inc.
o Exhibit 151: Biogen Inc. - Overview
o Exhibit 152: Biogen Inc. - Product / Service
o Exhibit 153: Biogen Inc. - Key offerings
o 12.9 Bristol Myers Squibb Co.
o Exhibit 154: Bristol Myers Squibb Co. - Overview
o Exhibit 155: Bristol Myers Squibb Co. - Product / Service
o Exhibit 156: Bristol Myers Squibb Co. - Key news
o Exhibit 157: Bristol Myers Squibb Co. - Key offerings
o 12.10 Eli Lilly and Co.
o Exhibit 158: Eli Lilly and Co. - Overview
o Exhibit 159: Eli Lilly and Co. - Product / Service
o Exhibit 160: Eli Lilly and Co. - Key news
o Exhibit 161: Eli Lilly and Co. - Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 162: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 163: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 164: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 165: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 166: F. Hoffmann La Roche Ltd. - Segment focus
o 12.12 Johnson and Johnson
o Exhibit 167: Johnson and Johnson - Overview
o Exhibit 168: Johnson and Johnson - Business segments
o Exhibit 169: Johnson and Johnson - Key news
o Exhibit 170: Johnson and Johnson - Key offerings
o Exhibit 171: Johnson and Johnson - Segment focus
o 12.13 Novartis AG
o Exhibit 172: Novartis AG - Overview
o Exhibit 173: Novartis AG - Business segments
o Exhibit 174: Novartis AG - Key offerings
o Exhibit 175: Novartis AG - Segment focus
o 12.14 Novo Nordisk AS
o Exhibit 176: Novo Nordisk AS - Overview
o Exhibit 177: Novo Nordisk AS - Business segments
o Exhibit 178: Novo Nordisk AS - Key offerings
o Exhibit 179: Novo Nordisk AS - Segment focus
o 12.15 Pfizer Inc.
o Exhibit 180: Pfizer Inc. - Overview
o Exhibit 181: Pfizer Inc. - Product / Service
o Exhibit 182: Pfizer Inc. - Key news
o Exhibit 183: Pfizer Inc. - Key offerings
o 12.16 Sanofi SA
o Exhibit 184: Sanofi SA - Overview
o Exhibit 185: Sanofi SA - Business segments
o Exhibit 186: Sanofi SA - Key news
o Exhibit 187: Sanofi SA - Key offerings
o Exhibit 188: Sanofi SA - Segment focus
o 12.17 Takeda Pharmaceutical Co. Ltd.
o Exhibit 189: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 190: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 191: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 192: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 193: Inclusions checklist
o Exhibit 194: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 195: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 196: Research methodology
o Exhibit 197: Validation techniques employed for market sizing
o Exhibit 198: Information sources
o 13.5 List of abbreviations
o Exhibit 199: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global bio-pharma market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Recombinant growth factors - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Recombinant growth factors - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Recombinant hormones - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Recombinant hormones - Year-over-year growth 2023-2028 (%)
Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits54: Market opportunity by Product ($ billion)
Exhibits55: Data Table on Market opportunity by Product ($ billion)
Exhibits56: Chart on Application - Market share 2023-2028 (%)
Exhibits57: Data Table on Application - Market share 2023-2028 (%)
Exhibits58: Chart on Comparison by Application
Exhibits59: Data Table on Comparison by Application
Exhibits60: Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Autoimmune disorder - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Autoimmune disorder - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Metabolic disorder - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Metabolic disorder - Year-over-year growth 2023-2028 (%)
Exhibits72: Chart on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Data Table on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
Exhibits74: Chart on Hormonal disorder - Year-over-year growth 2023-2028 (%)
Exhibits75: Data Table on Hormonal disorder - Year-over-year growth 2023-2028 (%)
Exhibits76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits78: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits79: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits80: Market opportunity by Application ($ billion)
Exhibits81: Data Table on Market opportunity by Application ($ billion)
Exhibits82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits83: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits84: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits85: Chart on Geographic comparison
Exhibits86: Data Table on Geographic comparison
Exhibits87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits115: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits116: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits117: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits118: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits121: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits122: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits123: Market opportunity By Geographical Landscape ($ billion)
Exhibits124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits125: Impact of drivers and challenges in 2023 and 2028
Exhibits126: Overview on Criticality of inputs and Factors of differentiation
Exhibits127: Overview on factors of disruption
Exhibits128: Impact of key risks on business
Exhibits129: Vendors covered
Exhibits130: Matrix on vendor position and classification
Exhibits131: AbbVie Inc. - Overview
Exhibits132: AbbVie Inc. - Product / Service
Exhibits133: AbbVie Inc. - Key news
Exhibits134: AbbVie Inc. - Key offerings
Exhibits135: Amgen Inc. - Overview
Exhibits136: Amgen Inc. - Product / Service
Exhibits137: Amgen Inc. - Key offerings
Exhibits138: Astellas Pharma Inc. - Overview
Exhibits139: Astellas Pharma Inc. - Product / Service
Exhibits140: Astellas Pharma Inc. - Key news
Exhibits141: Astellas Pharma Inc. - Key offerings
Exhibits142: AstraZeneca Plc - Overview
Exhibits143: AstraZeneca Plc - Product / Service
Exhibits144: AstraZeneca Plc - Key news
Exhibits145: AstraZeneca Plc - Key offerings
Exhibits146: Bayer AG - Overview
Exhibits147: Bayer AG - Business segments
Exhibits148: Bayer AG - Key news
Exhibits149: Bayer AG - Key offerings
Exhibits150: Bayer AG - Segment focus
Exhibits151: Biogen Inc. - Overview
Exhibits152: Biogen Inc. - Product / Service
Exhibits153: Biogen Inc. - Key offerings
Exhibits154: Bristol Myers Squibb Co. - Overview
Exhibits155: Bristol Myers Squibb Co. - Product / Service
Exhibits156: Bristol Myers Squibb Co. - Key news
Exhibits157: Bristol Myers Squibb Co. - Key offerings
Exhibits158: Eli Lilly and Co. - Overview
Exhibits159: Eli Lilly and Co. - Product / Service
Exhibits160: Eli Lilly and Co. - Key news
Exhibits161: Eli Lilly and Co. - Key offerings
Exhibits162: F. Hoffmann La Roche Ltd. - Overview
Exhibits163: F. Hoffmann La Roche Ltd. - Business segments
Exhibits164: F. Hoffmann La Roche Ltd. - Key news
Exhibits165: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits166: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits167: Johnson and Johnson - Overview
Exhibits168: Johnson and Johnson - Business segments
Exhibits169: Johnson and Johnson - Key news
Exhibits170: Johnson and Johnson - Key offerings
Exhibits171: Johnson and Johnson - Segment focus
Exhibits172: Novartis AG - Overview
Exhibits173: Novartis AG - Business segments
Exhibits174: Novartis AG - Key offerings
Exhibits175: Novartis AG - Segment focus
Exhibits176: Novo Nordisk AS - Overview
Exhibits177: Novo Nordisk AS - Business segments
Exhibits178: Novo Nordisk AS - Key offerings
Exhibits179: Novo Nordisk AS - Segment focus
Exhibits180: Pfizer Inc. - Overview
Exhibits181: Pfizer Inc. - Product / Service
Exhibits182: Pfizer Inc. - Key news
Exhibits183: Pfizer Inc. - Key offerings
Exhibits184: Sanofi SA - Overview
Exhibits185: Sanofi SA - Business segments
Exhibits186: Sanofi SA - Key news
Exhibits187: Sanofi SA - Key offerings
Exhibits188: Sanofi SA - Segment focus
Exhibits189: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits190: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits191: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits192: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits193: Inclusions checklist
Exhibits194: Exclusions checklist
Exhibits195: Currency conversion rates for US$
Exhibits196: Research methodology
Exhibits197: Validation techniques employed for market sizing
Exhibits198: Information sources
Exhibits199: List of abbreviations